TREATING CANCER WITH CRISPR/CAS9 TECHNOLOGY
Keywords:
Genetik tahrir, gen terapiyasi, immunoterapiya, onkogenez, genomni manipulyatsiya qilish, molekulyar biotexnologiyaAbstract
This article presents the potential of CRISPR-Cas9 technology in the treatment of cancer, its mechanisms of action. The article highlights the possibilities of the CRISPR-Cas9 system for precise genome editing, how it can be used as a therapy for cancer. The application of the technology in the fields of genetic manipulation, gene therapy, immunotherapy, as well as its achievements in the detection and destruction of cancer cells are discussed.
References
Jinek, M., & Doudna, J. A. (2012). A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science, 337(6096), 816-821. https://doi.org/10.1126/science.1225829
Zhang, F., Wen, Y., & Guo, X. (2014). Crispr/Cas9 for Genome Editing: Progress, Implications, and Applications. Journal of Human Genetics, 59(6), 342-349. https://doi.org/10.1038/jhg.2014.30
Sander, J. D., & Joung, J. K. (2014). CRISPR-Cas Systems for Editing, Regulating and Targeting Genomes. Nature Biotechnology, 32(4), 347-355. https://doi.org/10.1038/nbt.2842
Zetsche, B., Gootenberg, J. S., & Abudayyeh, O. O. (2015). Crispr-Cas9 Genome Editing in Human Cells: A Practical Guide. Trends in Biotechnology, 33(4), 293-299. https://doi.org/10.1016/j.tibtech.2015.02.003
Ma, H., & Zhang, L. (2019). CRISPR/Cas9-based Genome Editing: The Role of Targeted DNA Repair in Cancer Therapy. Cancer Research, 79(10), 2680-2689. https://doi.org/10.1158/0008-5472.CAN-18-3413
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Qo‘chqorxo‘jayev Saidburxon
This work is licensed under a Creative Commons Attribution 4.0 International License.
(+998)90 142-39-38
m.z.abdutolibov@gmail.com
@universal_jurnal
House 189 Kashgar Street, Marhamat district, Andijan region